Rush Enterprises, Inc. Reports Third Quarter 2017 Results
Oct 25, 2017 20:01 pm UTC| Business
Revenues of $1.257 billion, net income of $29.8 millionEarnings per diluted share of $0.72, a record highSolid activity in most market segments drove new truck sales and aftermarket performanceAbsorption ratio of 120.9% ...
Oct 25, 2017 20:01 pm UTC| Business
CAMBRIDGE, Mass., Oct. 25, 2017 -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today...
Merit Medical Reports Results for Third Quarter 2017
Oct 25, 2017 20:01 pm UTC| Business
Q3 2017 worldwide revenue of $179.3 million ($178.3 million on a comparable, constant currency* basis), up 14.2% as reported (up 13.6% on a comparable, constant currency* basis) over Q3 2016YTD 2017 worldwide revenue of...
Vital Therapies Announces Third Quarter 2017 Financial Results
Oct 25, 2017 20:01 pm UTC| Business
SAN DIEGO, Oct. 25, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for...
NETGEAR® Reports Third Quarter 2017 Results
Oct 25, 2017 20:01 pm UTC| Business
Third quarter 2017 net revenue of $355.5 million, as compared to $338.5 million in the comparable prior year quarter, an increase of 5.0%.Third quarter 2017 GAAP net income of $20.8 million, as compared to $21.1 million in...
Martin Midstream Partners Reports 2017 Third Quarter Financial Results
Oct 25, 2017 20:01 pm UTC| Business
Hurricane Harvey Impact Estimated at $6.0 MillionQuarterly Distribution Coverage Ratio Meets Internal ForecastYear to Date Distribution Coverage Ratio of 1.04x and Trailing Twelve Months Coverage Ratio of 1.27x KILGORE,...
Trevena Announces Publication and Presentations of OLINVO™ (oliceridine injection) Clinical Data
Oct 25, 2017 20:01 pm UTC| Business
– American Society of Anesthesiologists Annual Meeting presentations highlight OLINVO data from positive Phase 3 trials – – OLINVO Phase 2b data published in Journal of Pain Research – CHESTERBROOK, Pa., Oct. 25, 2017 ...